• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lyra Therapeutics, Inc. - Common Stock (NQ:LYRA)

2.200 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EST, Jan 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.200
Bid (Size) 2.160 (100)
Ask (Size) 2.500 (400)
Prev. Close 2.200
Today's Range 2.200 - 2.200
52wk Range 1.630 - 37.50
Shares Outstanding 31,836,815
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 15, 2025
 
Via Benzinga
News headline image
Lyra Therapeutics To Conduct One More Trial For Chronic Rhinosinusitis Treatment Candidate ↗
October 06, 2025
The company stated that the design of the new trial will be based on the learnings from the previous trials, in addition to FDA feedback. 
Via Stocktwits

Performance

YTD
-30.4%
-30.4%
1 Month
-38.2%
-38.2%
3 Month
-65.0%
-65.0%
6 Month
-73.0%
-73.0%
1 Year
-77.2%
-77.2%

More News

Read More
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
September 18, 2025
Via Benzinga
News headline image
Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial Finds ↗
September 02, 2025
Via Benzinga
News headline image
Is the Market Bullish or Bearish on Lyra Therapeutics? ↗
June 04, 2025
Via Benzinga
News headline image
Lyra Therapeutics Posts 85% Q2 Loss Drop ↗
August 12, 2025
Via The Motley Fool
News headline image
Which stocks are experiencing notable movement on Friday? ↗
June 27, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
June 27, 2025
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
June 27, 2025
Via Chartmill
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
June 27, 2025
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
June 27, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
June 09, 2025
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
June 09, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
June 04, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
June 03, 2025
Via Benzinga
News headline image
What's going on in today's session ↗
June 03, 2025
Via Chartmill
News headline image
Which stocks are moving on Tuesday? ↗
June 03, 2025
Via Chartmill
News headline image
US Stocks Likely To Open Lower: Expert Highlights Technical Analysis Showing S&P 500's 'Recovery Is Real' And Not A 'Bull Trap' Or 'Bear Market Rally' ↗
June 03, 2025
Via Benzinga
Topics Stocks
News headline image
Nasdaq Surges Over 100 Points Despite Renewed Trade Concerns: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone ↗
June 03, 2025
Via Benzinga
News headline image
Applied Digital Corp, Meta Platforms, Alphabet, Lyra Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
June 02, 2025
Via Benzinga
Topics Stocks
News headline image
Lyra Therapeutics Stock Skyrockets On Positive Trial Data For Its Nasal Implant: Retail’s Thrilled ↗
June 02, 2025
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
June 02, 2025
Via Benzinga
News headline image
Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May ↗
June 02, 2025
Via Benzinga
News headline image
Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings ↗
June 02, 2025
Via Benzinga
Topics Stocks
News headline image
Why Is Lyra Therapeutics Stock Surging Over 400% On Monday? ↗
June 02, 2025
Via Benzinga

Frequently Asked Questions

Is Lyra Therapeutics, Inc. - Common Stock publicly traded?
Yes, Lyra Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Lyra Therapeutics, Inc. - Common Stock trade on?
Lyra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lyra Therapeutics, Inc. - Common Stock?
The ticker symbol for Lyra Therapeutics, Inc. - Common Stock is LYRA on the Nasdaq Stock Market
What is the current price of Lyra Therapeutics, Inc. - Common Stock?
The current price of Lyra Therapeutics, Inc. - Common Stock is 2.200
When was Lyra Therapeutics, Inc. - Common Stock last traded?
The last trade of Lyra Therapeutics, Inc. - Common Stock was at 01/22/26 03:59 PM ET
What is the market capitalization of Lyra Therapeutics, Inc. - Common Stock?
The market capitalization of Lyra Therapeutics, Inc. - Common Stock is 70.04M
How many shares of Lyra Therapeutics, Inc. - Common Stock are outstanding?
Lyra Therapeutics, Inc. - Common Stock has 70M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap